Europe Biochips Market Forecast 2019-2028

Europe Biochips Market Forecast 2019-2028

The Europe biochips market is predicted to reach a CAGR of 12.98% over the estimated period, 2019-2028. The factors boosting the adoption of biochips in the genomics and biotechnology industry in Europe are R&D and technological innovation of biochip and microarrays platforms, gene profiling, management of diseases, and application of biochips in forensic and defense.

The Europe biochips market is researched further by dividing the region into countries such as Germany, Poland, France, Belgium, Russia, Italy, the UK, and the rest of Europe that includes Ireland, Greece, Sweden, Austria, Finland, Switzerland, and Portugal. The Russian healthcare system is highly decentralized. In April 2020, Russia’s FMBA rolled out two new test systems, based on coronavirus detection chips. One of the test systems allow reducing the testing time from 90 to 15-20 minutes, and the other test system is microfluidic chips that allow individual testing for coronavirus infection. The Belgian healthcare system is considered one of the best in the world. The country’s compulsory health insurance system came into existence in 1945. The Belgian start-up miDiagnostics is developing a technology for diagnosing diseases swiftly and precisely, and at the point-of-care using a silicon lab on a chip and nanoscale-precision microfluidics.
In Poland, the government has undertaken several initiatives to support new biotech companies. The country is becoming an emerging center for pharmaceutical companies and biotech startups. In the rest of Europe, there is an increased demand for a quick and accurate diagnosis due to the burden of the aging population and chronic diseases. This can be endowed by a lab on a chip and microarray technology. In Spain, the biotech and pharmaceutical companies are making huge investments, and expanding their share by meeting the needs for lab-on-a-chip services and POC testing.

Agilent Technologies, Inc, bioMerieux SA, Bio-Rad Laboratories Inc, Illumina, Inc, PerkinElmer Inc, etc. are one of the renowned companies operating in the region.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Parent Market Analysis: Genomics And Proteomics Market
3.2. Development Of Biochips
3.3. Market Definition
3.4. Key Drivers
3.4.1. Rising Incidences Of Chronic Diseases
3.4.2. Growing Interest In Personalized Medicines
3.4.3. Application Of Proteomics And Genomics In Cancer Research
3.4.4. Rapidly Growing Use Of Point-of-care Testing Diagnostics
3.5. Key Restraints
3.5.1. High Instrumentation Cost
3.5.2. Lack Of Awareness Among Common People About Biochip Technology
3.5.3. Availability Of Alternative Technology: Next Generation Sequencing (Ngs) Technology
3.5.4. Complexity Of Biological Systems
3.5.5. Lack Of Common Regulatory Standards
4. Key Analytics
4.1. Impact Of Covid-19 On Biochips
4.2. Key Investment Insights
4.3. Porter’s Five Force Analysis
4.3.1. Buyer Power
4.3.2. Supplier Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Value Chain Analysis
4.6.1. Research & Development
4.6.2. Raw Materials
4.6.3. Manufacturing
4.6.4. Wholesalers/Retailers/Distributors
4.6.5. End-user
4.7. Key Buying Criteria
4.7.1. Cost
4.7.2. Applications
4.7.3. Product Type
4.8. Regulatory Framework
5. Market By Type
5.1. Dna Chips
5.1.1. Agricultural Biotechnology
5.1.2. Cancer Diagnosis & Treatment
5.1.3. Drug Discovery
5.1.4. Gene Expression
5.1.5. Genomics
5.1.6. Single Nucleotide Polymorphism (Snp) Genotyping
5.1.7. Other Dna Chips
5.2. Lab On A Chip
5.2.1. Clinical Diagnostics
5.2.2. Drug Discovery
5.2.3. Genomics
5.2.4. Point Of Care & In Vitro Diagnosis
5.2.5. Proteomics
5.2.6. Other Lab On A Chip
5.3. Protein Chips
5.3.1. Diagnostics
5.3.2. Drug Discovery
5.3.3. Expression Profiling
5.3.4. High Throughput Screening
5.3.5. Proteomics
5.3.6. Other Protein Chips
5.4. Other Types
5.4.1. Cell Arrays
5.4.2. Tissue Arrays
6. Market By Substrate Materials
6.1. Glass
6.2. Polymers
6.3. Silicon
6.4. Other Substrate Materials
7. Market By End-user
7.1. Biotechnology And Pharmaceutical Companies
7.2. Hospitals And Diagnostics Centers
7.3. Academic And Research Institutes
8. Geographical Analysis
8.1. Europe
8.1.1. United Kingdom
8.1.2. Germany
8.1.3. France
8.1.4. Italy
8.1.5. Russia
8.1.6. Belgium
8.1.7. Poland
8.1.8. Rest Of Europe
9. Company Profiles
9.1. Abbott Laboratories Inc
9.2. Agilent Technologies Inc
9.3. Biochain Institute Inc
9.4. Biomérieux Sa
9.5. Bio-rad Laboratories Inc
9.6. Cepheid
9.7. Cybrdi Inc
9.8. F Hoffmann-la Roche Ltd
9.9. Fluidigm Corporation
9.10. Ge Healthcare
9.11. Illumina Inc
9.12. Merck Kgaa
9.13. Perkinelmer Inc
9.14. Randox Laboratories Ltd
9.15. Thermo Fisher Scientific Inc

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook